Effects of arteriovenous fistula on clinical, laboratory and echocardiographic findings in renal allograft recipients

International Journal of Artificial Organs

Volumn 34, Issue 10, 2011, Pages 1024-1030

  Gorgulu, Numan ^a   Caliskan, Yasar ^a   Yelken, Berna ^a   Akturk, Faruk ^b   Turkmen, Aydin ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Arteriovenous fistula; Echocardiographic findings; Renal transplantation

Indexed keywords

BLOOD PRESSURE; BODY FLUIDS; DIALYSIS; DISEASES; HEMODIALYZERS; PATENTS AND INVENTIONS;

ARTERIOVENOUS FISTULAS; ARTERY PRESSURE; ECHOCARDIOGRAPHIC FINDING; HEMODIALYSIS PATIENT; LEFT VENTRICLES; LEFT VENTRICULAR HYPERTROPHIES; MASS INDEX; PULMONARY ARTERY; RENAL TRANSPLANTATION; RENAL TRANSPLANTS;

ORGANIC ACIDS; BLOOD PRESSURE;

ANGIOTENSIN RECEPTOR ANTAGONIST; AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EVEROLIMUS; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAPAMYCIN; TACROLIMUS; THYROTROPIN; URIC ACID;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTERIOVENOUS FISTULA; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD SAMPLING; CARDIOVASCULAR RISK; CHRONIC GLOMERULONEPHRITIS; CHRONIC PYELONEPHRITIS; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HEART EJECTION FRACTION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART RIGHT ATRIUM; HEMODIALYSIS PATIENT; HUMAN; HYPERTENSION; HYPERURICEMIA; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY ARTERIOVENOUS FISTULA; KIDNEY BLOOD FLOW; KIDNEY FAILURE; LABORATORY TEST; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PERITONEAL DIALYSIS; POSTOPERATIVE PERIOD; PROTEIN BLOOD LEVEL; RENAL GRAFT DYSFUNCTION; RISK ASSESSMENT; SMOKING; URIC ACID BLOOD LEVEL;

EID: 83455231524     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.5301/ijao.5000005     Document Type: Article

References (26)

1. Go AS, Chertow GM, Fan D, McCulloch CE. Chronic kidney disease and the risk of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351(13):1296-1305. Medline. doi:10.1056/NEJMoa041031.
2. De Simone G, Pasanisi F, Contaldo F. Link of nonhemodynamic factors to hemodynamic determinants of left ventricular hypertrophy. Hypertension. 2001;38:13-18.
3. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray D, Barre PE. Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant. 1996;11:1277-1285.
4. Harnett JD, Kent GM, Barre PE, Taylor R. Risk factors for the development of left ventricular hypertrophy in a prospective followed cohort of dialysis patients. J Am Soc Nephrol. 1994;4:1486-1490.
5. Rigatto C, Foley R, Jeffery J, Negrijn C. Electrocardiographic left ventricular hypertrophy in renal transplant recipients: prognostic value and impact of blood pressure and anemia. J Am Soc Nephrol. 2003;14(2):462-468. Medline. doi:10.1097/01.ASN.0000043141.67989.39.
6. Meeus F, Kourilsky O, Guerin AP, Gaudry C. Pathophysiology of cardiovascular disease in hemodialysis patients. Kidney Int. 2000;58:140-147. doi:10.1046/j.1523-1755.2000.07618.x.
7. Foley RN, Parfrey PS, Harnett JD, Kent GM. Clinical and echocardiographic disease in patients starting end-stage renal disease therapy. Kidney Int. 1995;47:186-192. Medline. doi:10.1038/ki.1995.22.
8. De Lima JJG, Abensur H, Fonseca JA, Krieger EM. Comparison of echocardiographic changes associated with hemodialysis and renal transplantation. Artif Organs. 1995;19(3):245-250. Medline. doi:10.1111/j.1525-1594.1995.tb02322.x.
9. Hüting J. Course of left ventricular hypertrophy and function in end-stage renal disease after renal transplantation. Am J Cardiol. 1992;70(18):1481-1484. Medline. doi:10.1016/0002- 9149(92)90303-G.
10. Peteiro J, Alvarez N, Calvino R, Penas M. Changes in left ventricular mass and filling after renal transplantation are related to changes in blood pressure: An echocardiographic and pulsed Doppler study. Cardiology. 1994;85:273-283. Medline. doi:10.1159/000176695.
11. Ferreira SRC, Moises VA, Tavares A, Pacheco-Silva A. Cardiovascular effects of successful renal transplantation: a 1-year sequential study of left ventricular morphology and function, and 24-hour blood pressure profile. Transplantation. 2002;74:1580-1587. Medline. doi:10.1097/00007890- 200212150-00016.
12. London G. Pathophysiology of cardiovascular damage in the early renal population. Nephrol Dial Transplant. 2001;16:3-6. Medline.
13. Reis GJ, Hirsch AT, Come PC. Detection and treatment of high-output cardiac failure resulting from a large hemodialysis fistula. Cathet Cardiovasc Diagn. 1988;14(4):263-265. doi:10.1002/ccd.1810140409.
14. Engelberts I, Tordoir JHM, Boon ES, Screij G. High-output cardiac failure due to excessive shunting in a hemodialysis access fistula. An easily overlooked diagnosis. Am J Nephrol. 1995;15:323-326. Medline. doi:10.1159/000168857.
15. Sahn DJ, De Maria A, Kisslo J, Weyman A. The committee on M-mode standardization of the American society of echocardiography. Recommendations regarding quantitation in Mmode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58:1072-1083.
16. Burgess MI, Bright-Thomas RJ, Ray SG. Echocardiographic evaluation of right ventricular function. Eur J Echocardiogr 2002;3:252-262. doi:10.1053/euje.2002.0172.
17. Parfrey PS, Harnett JD, Foley RN. Impact of renal transplantation on uremic cardiomyopathy. Transplantation. 1995; 60: 908-914.
18. McGregor E, Stewart G, Rodger RS, Jardine AG. Early echocardiographic changes and survival following renal transplantation. Nephrol Dial Transplant. 2000;15(1):93-98. Medline. doi:10.1093/ndt/15.1.93.
19. Kooman JP, Leunissen KML. Cardiovascular aspects in renal disease. Curr Opin Nephrol Hypertens. 1993;2(5):791-797.
20. London GM, Guerin AP, Marchais SJ. Hemodynamic overload in end stage renal disease patients. Semin Dial. 1999;12(2):77-83. doi: 10.1046/j.1525-139x.1999.00007.x.
21. van Duijnhoven ECM, Cheriex ECM, Tordoir JHM, Koman JP. Effects of closure of the arteriovenous fistula on left ventricular dimensions in renal transplant patients. Nephrol Dial Transplant. 2001;16:368-372. Medline. doi:10.1093/ ndt/16.2.368.
22. Unger P, Roa SV, Wissing KM, Hoang AD. Regression of left ventricular hypertrophy after arteriovenous fistula closure in renal transplant recipients: a long-term follow-up. Am J Transplant. 2004;4:2038-2044. Medline. doi:10.1046/j.1600- 6143.2004.00608.x.
23. Cridlig J, Suty C, Alla F, Chodek A. Cardiac impact of the arteriovenous fistula after kidney transplantation: a case-controlled, match-paired study. Transpl Int. 2008;21:948-954. Medline. doi:10.1111/j.1432-2277.2008.00707.x.
24. De Lima JJ, Vieira ML, Molnar LJ, Medeiros CJ. Cardiac effects of persistent hemodialysis arteriovenous access in recipients of renal allograft. Cardiology. 1999;92:236-239. Medline. doi:10.1159/000006980.
25. Zhang YH, Lü R, Zhao XY, Kang LM. Association of serum uric acid, plasma NT-proBNP, hs-C reactive protein and invasive hemodynamic parameters in patients with heart failure. Zhonghua Xin Xue Guan Bing Za Zhi. 2009;37:126-129.
26. Karbowska A, Boratynska M, Kusztal M, Klinger M. Hyperuricemia is a mediator of endothelial dysfunction and inflammation in renal allograft recipients. Transplant Proc. 2009; 41: 3052-3055. Medline. doi:10.1016/j.transproceed. 2009.07.080.